申请人:Dainippon Pharmaceutical Co., Ltd.
公开号:US04201781A1
公开(公告)日:1980-05-06
Cephalosporin compounds of the formula ##STR1## wherein R is 1-carboxymethyl-1,2,3,4-tetrazol-5-yl or 5-carboxymethyl-1,3,4-thiadiazol-2-yl, and non-toxic pharmaceutically acceptable salts thereof, and processes for preparing them. The compounds have superior antibacterial activity and excellent solubility in an aqueous medium, and are useful as antibacterial agent.
该化合物的头孢菌素类化合物的式子为 ##STR1## 其中R为1-羧甲基-1,2,3,4-四唑-5-基或5-羧甲基-1,3,4-噻二唑-2-基,以及其无毒的药学上可接受的盐和制备它们的过程。这些化合物具有出色的抗菌活性和在水性介质中的优异溶解性,可用作抗菌剂。